Universal-Beteiligungs- und Servicegesellschaft’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.68M Sell
36,634
-1,372
-4% -$94.3K ﹤0.01% 1188
2026
Q1
$2.43M Buy
38,006
+10,705
+39% +$743K ﹤0.01% 1178
2025
Q4
$2.17M Buy
27,301
+15,863
+139% +$1.34M ﹤0.01% 1229
2025
Q3
$756K Buy
11,438
+4,062
+55% +$242K ﹤0.01% 1631
2025
Q2
$391K Buy
7,376
+985
+15% +$46.3K ﹤0.01% 1750
2025
Q1
$317K Buy
+6,391
New +$355K ﹤0.01% 1770

Other funds holding IRON

Universal-Beteiligungs- und Servicegesellschaft's IRON Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Disc Medicine (IRON) stake by 3.6% in Q2 2026, selling an estimated $94.3K and leaving 36,634 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in IRON in Q1 2025 and has held it in 6 quarters since. 92 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 36,634 shares of Disc Medicine worth $2.68M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 1,372 Disc Medicine shares in Q2 2026, an estimated $94.3K.
  • Disc Medicine made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1188 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Disc Medicine in Q1 2025 and has held it in 6 quarters since.
  • 92 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.